Literature DB >> 12037068

Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Frédéric Barbut1, Valérie Lalande, Béatrice Burghoffer, Huong Vu Thien, Emmanuel Grimprel, Jean-Claude Petit.   

Abstract

Toxin A variant strains (toxin A-negative, toxin B-positive strains) of Clostridium difficile have been reported to be responsible for diarrhea or pseudomembranous colitis in humans. These strains lack parts of the repeating sequences of the toxin A gene (tcdA) and are toxin A negative by commercial enzyme immunoassays (EIA). Here, we report the prevalence of the toxin A variant strains in 334 patients with C. difficile-associated diarrhea in France. The repeating segment of the tcdA gene (1,200 bp) was amplified by PCR using the primers NK9 and NK11 (H. Kato et al., J. Clin. Microbiol. 36:2178-2182, 1998). In the case of amplified fragments of unexpected size, the entire tcdA gene was studied by PCRs A1, A2, and A3 (Rupnik et al., J. Clin. Microbiol. 36:2240-2247, 1998), and strains were characterized by serotyping, pulsed-field gel electrophoresis and PCR ribotyping. By PCR with primers NK9 and NK11, C. difficile variant strains were detected in 2.7% of patients. Several variant types were found. A deletion of approximately 1,700 bp was observed in six strains from five patients. These strains belonged to serotype F and were characterized by the same pulsotype and the same PCR ribotype. They were toxin A negative by EIA and exhibited an atypical cytopathic effect on MRC-5 cells. Two other tcdA variant types that exhibited a positive result for toxin A by EIA were identified: one from serotype H with a longer amplified fragment (insertion of 200 bp) and one with a deletion of 600 bp. Diagnosis of C. difficile-associated diseases would have been missed in five patients (1.5%) by laboratories that screen the stools only for the presence of toxin A. This result underlines the need for testing stool by the cytotoxicity assay in patients with a high suspicion of C. difficile-associated diarrhea but a negative immunoassay for toxin A.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037068      PMCID: PMC130789          DOI: 10.1128/JCM.40.6.2079-2083.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Prevalence of toxin A negative/B positive Clostridium difficile strains.

Authors:  J S Brazier; S L Stubbs; B I Duerden
Journal:  J Hosp Infect       Date:  1999-07       Impact factor: 3.926

2.  Usefulness of simultaneous detection of toxin A and glutamate dehydrogenase for the diagnosis of Clostridium difficile-associated diseases.

Authors:  F Barbut; V Lalande; G Daprey; P Cohen; N Marle; B Burghoffer; J C Petit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-06       Impact factor: 3.267

3.  Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.

Authors:  S P Sambol; M M Merrigan; D Lyerly; D N Gerding; S Johnson
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes.

Authors:  Maja Rupnik; Jon S Brazier; Brian I Duerden; Miklavz Grabnar; Simon L J Stubbs
Journal:  Microbiology (Reading)       Date:  2001-02       Impact factor: 2.777

5.  Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea.

Authors:  M J Alfa; A Kabani; D Lyerly; S Moncrief; L M Neville; A Al-Barrak; G K Harding; B Dyck; K Olekson; J M Embil
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile.

Authors:  S Stubbs; M Rupnik; M Gibert; J Brazier; B Duerden; M Popoff
Journal:  FEMS Microbiol Lett       Date:  2000-05-15       Impact factor: 2.742

7.  Purification and characterization of toxins A and B of Clostridium difficile.

Authors:  N M Sullivan; S Pellett; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Analysis of the pathogenicity locus in Clostridium difficile strains.

Authors:  S H Cohen; Y J Tang; J Silva
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR.

Authors:  J S Moncrief; L Zheng; L M Neville; D M Lyerly
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

10.  Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett; N Moon; T W Chang; N Taylor; A B Onderdonk
Journal:  Gastroenterology       Date:  1978-11       Impact factor: 22.682

View more
  23 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China.

Authors:  Pengcheng Du; Bo Cao; Jing Wang; Wenge Li; Hongbing Jia; Wen Zhang; Jinxing Lu; Zhongjie Li; Hongjie Yu; Chen Chen; Ying Cheng
Journal:  J Clin Microbiol       Date:  2014-06-23       Impact factor: 5.948

3.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia.

Authors:  Maja Rupnik; Naoki Kato; Miklavz Grabnar; Haru Kato
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.

Authors:  Bobby L Boyanton; Preethi Sural; Caroline R Loomis; Christine Pesta; Laura Gonzalez-Krellwitz; Barbara Robinson-Dunn; Paul Riska
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

6.  Rapid and simple method for detecting the toxin B gene of Clostridium difficile in stool specimens by loop-mediated isothermal amplification.

Authors:  Haru Kato; Toshiyuki Yokoyama; Hideaki Kato; Yoshichika Arakawa
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.

Authors:  Bo-Moon Shin; Eun Young Kuak; Eun Joo Lee; J Glenn Songer
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

8.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile.

Authors:  Carina Gonçalves; Dominique Decré; Frédéric Barbut; Béatrice Burghoffer; Jean-Claude Petit
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

Review 10.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.